1-4 of 4
Joost J Oudejans, MD, PhD
Close
Sort by
Journal Articles

Bortezomib Restores Defective Apoptosis by Upregulation of Noxa in Enteropathy-Associated T-Cell Lymphoma

Laura R de Baaij, MD, Marijn Radersma, MD, Jolanda MW van de Water, MD, Kim BJ Groot, Nathalie J Hijmering, Laura M Moesbergen, Otto J Visser, MD, Joost J Oudejans, MD, PhD, Chris JJ Mulder, MD, PhD, Chris JLM Meijer, MD, PhD, Saskia AGM Cillessen, PhD
Journal: Blood
Blood (2011) 118 (21): 2722.
https://doi.org/10.1182/blood.V118.21.2722.2722
Published: 2011
Journal Articles

Enteropathy-Associated T-Cell Lymphoma: a Clinical Prognostic Model to Identify High Risk Patients

Laura R de Baaij, MD, Jolanda MW van de Water, MD, Wieke HM Verbeek, MD, PhD, Otto J Visser, MD, Dirk J Kuik, Msc, Joost J Oudejans, MD, PhD, Chris JLM Meijer, MD, PhD, Chris JJ Mulder, MD, PhD, Saskia AGM Cillessen, PhD
Journal: Blood
Blood (2010) 116 (21): 3092.
https://doi.org/10.1182/blood.V116.21.3092.3092
Published: 2010
Journal Articles

Bortezomib Induces Caspase-9-Mediated Apoptosis through Activation of the BH3-Only Proteins Noxa, Bik and Puma In Both ALK-Positive and ALK-Negative Anaplastic Large Cell Lymphoma Cells

Saskia AGM Cillessen, PhD, Nathalie J Hijmering, Laura M Moesbergen, Gert J. Ossenkoppele, MD, PhD, Joost J Oudejans, MD, PhD, Chris JLM Meijer, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2847.
https://doi.org/10.1182/blood.V116.21.2847.2847
Published: 2010
Journal Articles

Profiling of Caspase Signaling Pathways Predicts Clinical Response to Chemotherapy in Diffuse Large B-Cell Lymphomas.

Joost J. Oudejans, MD, PhD, Jettie J.F. Muris, MD, Gert J. Ossenkoppele, MD, PhD, Saskia A.G.M. Cillessen, Inge van Houdt, Alain J. Kummer, MD, PhD, Han van Krieken, MD, PhD, Hanneke C. Kluin-Nelemans, MD, PhD, Chris J.L.M. Meijer, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 1544.
https://doi.org/10.1182/blood.V104.11.1544.1544
Published: 2004